Epidemiology and clinical characteristics of seizures in patients with acute intermittent porphyria

Epilepsia

Volumn 37, Issue 3, 1996, Pages 230-235

  Bylesjö, Ingemar ^a   Forsgren, Lars ^a   Lithner, Folke ^a   Boman, Kurt ^b  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b Department of Internal Medicine ^*  (Sweden)

Author keywords

Acute intermittent porphyria; Epidemiology; Seizures; Sweden

Indexed keywords

AMINOLEVULINIC ACID;

ACUTE INTERMITTENT PORPHYRIA; ADOLESCENT; ADULT; ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPONATREMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SEIZURE; SODIUM BLOOD LEVEL; SWEDEN;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; COMORBIDITY; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; PORPHYRIA, ACUTE INTERMITTENT; PREVALENCE; REGISTRIES; SEX FACTORS; SWEDEN;

EID: 0030050002     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1996.tb00018.x     Document Type: Article

References (49)

1. Kappas A, Sassa S, Andersson KE. The porphyrias. In: Stanbury JB, Wyngaarden JB, Fredrikson DS, Goldstein JL, Brown MS, eds. The metabolic basis of inherited disease. New York: McGraw-Hill, 1989:1305-65.
2. Desnick RJ, Ostasiewitz LT, Tishler PA, Mustajoki P. Acute intermittent porphyria: characterization of a novel mutation in the structural gene for porphobilinogen deaminase. J Clin Invest 1985;76:865-74.
3. Lannfelt L. Porphobilinogen deaminase by ELISA as a diagnostic measure in acute intermittent porphyria. J Clin Chem Clin Biochem 1990;10:273-8.
4. Mustajoki P, Desnick RJ. Genetic heterogeneity in acute intermittent porphyria: characterisation and frequency of porphobilinogen deaminase mutations in Finland. Br Med J 1985;291:505-9.
5. Jennekens FGI. Peripheral neuropathy in metabolic disorders. In: Vinken PJ, Bruyn GW, Klawans HL, Matthews WB, eds. Handbook of clinical neurology, vol.7 (51): neuropathies. Amsterdam: Elsevier Science Publishers BV, 1987:367-411.
6. Evans OB, Bock H-E O, Parker C, Hanson RR. Inborn errors of metabolism of the central nervous system. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, eds. Neurology in clinical practice. Boston: Butterworth-Hememann, 1991:1293-4.
7. Kauppinen R, Mustajoki P. Prognosis of acute porphyria: occurrence of acute attacks, precipitating factors, and associated diseases. Medicine 1992;71:1-13.
8. Bonkowsky HL, Schady W. Neurologic manifestations of acute porphyria. Semin Liver Dis 1982;2:108-24.
9. Laiwah ACY, Moore MR, Goldberg A. Pathogenesis of acute porphyria. Q J Med 1987;241:377-92.
10. Berg M. Acute porphyria: clinical and pathological observations. Arch Intern Med 1945;76:335-40.
11. Denny-Brown D, Sciara D. Changes in the nervous system in acute porphyria. Brain 1945;68:1-16.
12. Hierons R. Changes in the nervous system in acute porphyria. Brain 1957;80:176-92.
13. Lai C-W, Hung T-P, Lin WSJ. Blindness of cerebral origin in acute intermittent porphyria: report of a case and postmortem examination. Arch Neurol 1977;34:310-2.
14. King PH, Bragdon AC. MRI reveals multiple reversible cerebral lesions in an attack of acute intermittent porphyria. Neurology 1991;41:1300-2.
15. Aggarwal A, Quint DJ, Lynch JP. MR imaging of porphyric encephalopathy. AJR 1994;162:1218-20.
16. Nielsen B, Thorn NA. Transient excess urinary excretion of antiduretic material in acute intermittent porphyria with hyponatremia and hypomagnesemia. Am J Med 1965;38:345-58.
17. Goldberg A, Rimington C. Diseases of porphyrin metabolism. Springfield, IL: Charles C Thomas, 1962:64-106.
18. Stein JA, Tschudy DP. Acute intermittent porphyria. A clinical and biochemical study of 46 patients. Medicine 1970;49: 1-16.
19. Manzerall D, Granick S. The occurrence and determination of delta aminolevulinic acid and porphobilinogen in urine. J Biol Chem 1956;219:435-6.
20. Lee J-S. Molecular genetic investigation of the human porphobilinogen deaminase gene in acute intermittent porphyria. Ph.D. diss, Department of Clinical Genetics, Karolinska Hospital and Department of Psychiatry, St Görans Hospital, Stockholm, 1991.
21. Lundin G, Wedell A, Thunell S, Anvret M. Two new mutations in the porphobilinogen deaminase gene and a screening method using PCR ampliation of specific alleles. Hum Genet 1994;93:59-62.
22. Lee J-S, Grandchamp B, Anvret M. A point mutation of the human porphobilinogen deaminase gene in a Swedish family with acute intermittent porphyria. Am J Hum Genet 1990; 47(suppl):3932.
23. Grandchamp B, Picat C, Kauppinen R, et al. Molecular analysis of acute intermittent porphyria in a Finnish family with normal erythrocyte porphobilinogen deaminase. Eur J Clin Invest 1989;19:415-8.
24. Grandchamp B, Picat C, Mignotte V, et al. Tissue-specific splicing mutation in acute intermittent porphyria. Proc Natl Acad Sci USA 1989;86:661-4.
25. Commission on Classification and Terminology of the ILAE. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22:489-501.
26. Wetterberg L. Neuropsychiatric and genetical investigation of acute intermittent porphyria. Stockholm: Nordstedts, 1967.
27. Forsgren L. Prevalence of epilepsy in adults in northern Sweden. Epilepsia 1992;33:450-8.
28. Annegers JF, Hauser WA. Epidemiologic measures of occurrence and association for the study of convulsive disorders. In: Porter RJ, Mattson RH, Ward AA, Dam M, eds. Advances in epileptology: the XVth Epilepsy International Symposium. New York: Raven Press, 1984:521-9.
29. Juul-Jensen P, Foldspang A. Natural history of epileptic seizures. Epilepsia 1983;24:297-312.
30. Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia 1991; 32:429-45.
31. Haerer AF, Anderson DW, Schoenberg BS. Prevalence and clinical features of epilepsy in a biracial United States population. Epilepsia 1986;27:66-75.
32. Nuytten D, Van Hees J, Meulemans A, Carton H. Magnesium deficiency as a cause of intractable seizures. J Neurol 1991;238:262-4.
33. Arieff AI. Effects of water, acid-base and electrolyte disorders on the central nervous system. In: Arieff AI, Defronzo RA, eds. Fluid, electrolyte and acic-base disorders. New York: Churchill Livingstone, 1985:992-1007.
34. Biagini R, Tignani R, Fifi AR, Nappini L. Acute intermittent porphyria and epilepsy. Arch Dis Child 1979;54:644-5.
35. Birchfield RI, Cowger ML. Acute intermittent porphyria with seizures. Am J Dis Child 1996;112:561-5.
36. Suzuki A, Aso K, Ariyoshi C, Ishimarn M. Acute intermittent porphyria and epilepsy: safety of clonazepam. Epilepsia 1991;33:108-11.
37. Davidson R. Acute porphyria in an epileptic. Br J Clin Pract 1963;17:33-6.
38. Larson AW, Wasserstrom WR, Felsher BF, Shih JC. Posttraumatic epilepsy and acute intermittent porphyria: effects of phenytoin, carbamazepine and clonazepam. Neurology 1978;28:824-8.
39. Bonkowsky HL, Sinclair PR, Emery S, Sinclair JF. Seizure management in acute hepatic porphyria: risk of valproate and clonazepam. Neurology 1980;30:558-92.
40. Kaplan PW, Lewis DV, Juvenile acute intermittent porphyria with hypercholesterolemia and epilepsy: a case report and review of the literature. J Child Neurol 1986;1:38-45.
41. Magnussen CR, Doherty JM, Hess RA, Tschudy DP. Grand mal seizures and acute intermittent porphyria. Neurology 1975;25:1121-5.
42. Sadeh M, Blatt I, Martonovits G, Karni A, Goldhammer Y. Treatment of porphyric convulsions with magnesium sulfate. Epilepsia 1991;32:712-5.
43. Wirtschafter JD, Turner FW, Dow RS. Convulsive seizures as the presenting manifestation of intermittent porphyria. Neurology 1960;10:787-92.
44. Lai C-W. Carbamazepine in seizure management in acute intermittent porphyria Neurology 1981;31:232.
45. Herrick AL, McColl KEL, Moore MR, Brodie MJ, Adamson AR, Goldberg A. Acute intermittent porphyria in two patients on anticonvulsant therapy and with normal erythrocyte porphobilinogen deaminase activity. Br J Clin Pharmacol 1989;27:491-7.
46. Gretter T, Danner P, Nibbelink D, Green D, Sahs AL. The effect of diphenylhydantoin (Dilantin) on acute intermittent porphyria. Trans Am Neurol Assoc 1963;88:176-8.
47. Waldenström J. Studien über Porphyrie. Acta Med Scand 1937;82(suppl):1-254.
48. Reynolds NC, Miska RM. Safety of anticonvulsants in hepatic porphyrias. Neurology 1981;31:232.
49. Tatum WO, IV, Zachariah SB. Gabapentin in treatment of seizures in acute intermittent porphyria (AIP). Neurology 1995;45:1216-7.